Parathyroid Hormone 1-34(Teriparatide) Treatment in Pelvic Insufficiency Fractures: A Report of Two Cases.
10.11005/jbm.2012.19.2.147
- Author:
Sang Won MOON
1
;
Dong Hyun LEE
;
Young Chang KIM
;
Young Bok KIM
;
Sang Jin LEE
;
Ji Wan KIM
Author Information
1. Department of Orthopaedic Surgery, Haeundae Paik Hospital, College of Medicine, Inje University, Busan, Korea. bakpaker@hanmail.net
- Publication Type:Case Report
- Keywords:
Osteoporosis;
Parathyroid hormone;
Pelvis;
Pelvis (Pelvic) insufficiency fracture
- MeSH:
Aged;
Aging;
Comorbidity;
Dependency (Psychology);
Fractures, Stress;
Humans;
Incidence;
Osteoporosis;
Parathyroid Hormone;
Pelvis
- From:Journal of Bone Metabolism
2012;19(2):147-151
- CountryRepublic of Korea
- Language:English
-
Abstract:
As a result of aging population, the incidence of pelvic insufficiency fracture has been increasing. Pain-related immobility caused by pelvic insufficiency fractures may result in a serious dependency and high mortality with preexisting comorbidities. We present two cases of pelvic insufficiency fracture in elderly patients which had good clinical outcome by parathyroid hormone 1-34(teriparatide) treatment as well as a literature review.
